Oncology Medication Market
Oncology Medication Market Scope: Industry
Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Oncology Medication Market Size and Growth
The oncology medication market is experiencing robust growth, driven by increasing cancer prevalence and advancements in targeted therapies. The global market size reached approximately $150 billion in 2023, with a projected compound annual growth rate (CAGR) of 10% through 2030. Key trends include personalized medicine and expanding immunotherapy options.
Companies Covered
(Covid 19 Impact Covered)
◍ Roche
◍ Celgene
◍ Novartis
◍ Bristol-Myers Squibb
◍ Johnson & Johnson
◍ Merck & Co.
◍ AstraZeneca
◍ Pfizer
◍ Amgen
◍ Takeda
◍ Astellas
◍ Ipsen
◍ Sanofi
◍ Bayer
◍ Biogen Idec
The oncology medication market features key players like Roche, Celgene, Novartis, and others, driving growth through innovative therapies and partnerships. Companies enhance market presence with strategic acquisitions, research advancements, and expanded indications. Revenue highlights include:
- Roche: Approx. $48 billion
- Novartis: Approx. $50 billion
- Merck & Co.: Approx. $46 billion
Request Sample Report
Market Segmentation
By Application
◍ Gastrointestinal Cancer
◍ Prostate Cancer
By Product
Others ◍ Blood Cancer ◍ Breast Cancer
◍ Respiratory or Lung Cancer ◍ Others
◍ Chemotherapy Medication
◍ Targeted Therapy Medication
◍ Immunotherapy Medication ◍ Hormonal Therapy Medication
Request Sample Report
Market Growth
Request Sample Report
$ 3.06 Billion
